F8 protein, human: Clinical Trials

6 trials of F8 protein, human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 terminated. 6 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Not yet recruiting 1, Terminated 1
Phase 32Completed 1, Not yet recruiting 1

Follow F8 protein, human: new trials by email Literature Review of F8 protein, human trials Research Report on F8 protein, human

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
Emicizumab Injection, Factor VIII (FVIII) - Hemophilia A
Phase 2 / Phase 3Not yet recruitingDhaka Medical College202025-06-012025-04-22
Weight-based Dosing in Hemophilia A
rFVIII - Hemophilia
Phase 2TerminatedCraig Seaman302015-09-012020-09-25
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A
rVIII-SingleChain, Octocog alfa - Hemophilia A
Phase 2 / Phase 3CompletedCSL Behring1752012-02-012016-08-09
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A
Human-cl rhFVIII, Kogenate FS - Hemophilia A
Phase 2CompletedOctapharma222010-05-012019-10-08
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A
Kogenate FS, Advate, or Humate-P, Recombinate, Helixate FS - Hemophilia A
Phase 2CompletedThe Hospital for Sick Children142008-07-012020-10-08
Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.
Kogenate FS, reconstituted in a suspension of liposomes - Haemophilia A
Phase 2CompletedRecoly N.V.162005-10-012007-10-16

Conditions studied

Hemophilia A (6)  ·  Hemostatic Disorders (1)

Sponsors

CSL Behring (1)  ·  Craig Seaman (1)  ·  Dhaka Medical College (1)  ·  Octapharma (1)  ·  Recoly N.V. (1)  ·  The Hospital for Sick Children (1)

Countries

United States (3)  ·  Canada (2)  ·  Germany (2)  ·  Russia (2)  ·  Australia (1)  ·  Austria (1)  ·  Bangladesh (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Malaysia (1)  ·  Netherlands (1)

Top investigators

Akhil R. Biswas, MBBS, FCPS (1)  ·  Brian Feldman, MD,MSc,FRCPC (1)  ·  Craig Seaman, MD, MS (1)  ·  Jack Spira, MD. PhD. (1)  ·  Sigurd Knaub, PhD (1)

Results publications

PMID 27330001, PMID 29296836, PMID 31697801, PMID 38853005